A detailed history of Mml Investors Services, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mml Investors Services, LLC holds 7,621 shares of BMRN stock, worth $507,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,621
Previous 7,049 8.11%
Holding current value
$507,787
Previous $580,000 7.59%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$69.02 - $93.84 $39,479 - $53,676
572 Added 8.11%
7,621 $536,000
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $94,749 - $117,396
-1,273 Reduced 15.3%
7,049 $580,000
Q1 2024

May 14, 2024

SELL
$83.81 - $99.0 $368,847 - $435,699
-4,401 Reduced 34.59%
8,322 $727,000
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $283,462 - $366,358
3,719 Added 41.3%
12,723 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $46,788 - $51,964
550 Added 6.51%
9,004 $797,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $175,440 - $203,007
2,024 Added 31.48%
8,454 $733,000
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $37,377 - $49,957
426 Added 7.1%
6,430 $625,000
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $6,312 - $8,473
78 Added 1.32%
6,004 $621,000
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $13,556 - $15,995
165 Added 2.86%
5,926 $502,000
Q2 2022

Aug 12, 2022

SELL
$71.48 - $86.85 $214,082 - $260,115
-2,995 Reduced 34.21%
5,761 $477,000
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $387,295 - $483,285
-5,214 Reduced 37.32%
8,756 $675,000
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $55,367 - $70,614
772 Added 5.85%
13,970 $1.23 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $16,598 - $18,974
-222 Reduced 1.65%
13,198 $1.02 Million
Q2 2021

Aug 13, 2021

BUY
$75.51 - $84.79 $185,150 - $207,905
2,452 Added 22.36%
13,420 $1.12 Million
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $53,656 - $65,115
718 Added 7.0%
10,968 $828,000
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $18,660 - $23,181
-257 Reduced 2.45%
10,250 $899,000
Q3 2020

Nov 13, 2020

SELL
$71.87 - $131.03 $86,387 - $157,498
-1,202 Reduced 10.27%
10,507 $799,000
Q2 2020

Aug 14, 2020

SELL
$79.55 - $124.22 $64,355 - $100,493
-809 Reduced 6.46%
11,709 $1.44 Million
Q1 2020

May 14, 2020

BUY
$71.37 - $96.85 $20,697 - $28,086
290 Added 2.37%
12,518 $1.06 Million
Q4 2019

Feb 11, 2020

BUY
$64.27 - $86.37 $16,131 - $21,678
251 Added 2.1%
12,228 $1.03 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $105,144 - $132,771
-1,560 Reduced 11.52%
11,977 $807,000
Q2 2019

Aug 13, 2019

BUY
$80.35 - $93.9 $145,433 - $169,959
1,810 Added 15.43%
13,537 $1.16 Million
Q1 2019

May 10, 2019

BUY
$84.2 - $98.62 $214,289 - $250,987
2,545 Added 27.72%
11,727 $1.04 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $117,725 - $155,816
1,469 Added 19.05%
9,182 $782,000
Q3 2018

Nov 07, 2018

BUY
$93.92 - $105.72 $282,605 - $318,111
3,009 Added 63.97%
7,713 $748,000
Q2 2018

Aug 13, 2018

BUY
$76.01 - $99.03 $144,799 - $188,652
1,905 Added 68.06%
4,704 $443,000
Q1 2018

May 11, 2018

BUY
$77.67 - $92.63 $217,398 - $259,271
2,799 New
2,799 $227,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.